[Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D005965:Glucuronates / Q000494:pharmacology* / Q000627:therapeutic use*; D006025:Glycosaminoglycans / Q000494:pharmacology* / Q000627:therapeutic use; D006496:Heparinoids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D013923:Thromboembolism / Q000188:drug therapy
D005965:Glucuronates; D006025:Glycosaminoglycans; D006496:Heparinoids; D008055:Lipids; D008074:Lipoproteins
Effetti chiarificante ed antiaggregante piastrinico di un eparinoide di origine naturale